[p170 in multiple myeloma and acute leukemia].
Riccardi
A
A
Clinica Medica II, Università ed IRCCS Policlinico S. Matteo, Pavia.
Invernizzi
R
R
Ucci
G
G
Luoni
R
R
Danova
M
M
Giordano
M
M
Zambelli
M L
ML
Rastaldi
M P
MP
Ascari
E
E
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000493:pharmacokinetics / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D003110:Colonic Neoplasms / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004351:Drug Resistance; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008562:Membrane Glycoproteins / Q000032:analysis*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality; D009363:Neoplasm Proteins / Q000032:analysis*; D014411:Neoplastic Stem Cells / Q000201:enzymology; D010440:Peptichemio / Q000008:administration & dosage; D010950:Plasma Cells / Q000201:enzymology; D011241:Prednisone / Q000494:pharmacology; D012074:Remission Induction; D015996:Survival Rate; D014407:Tumor Cells, Cultured / Q000201:enzymology; D014750:Vincristine / Q000008:administration & dosage
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D014408:Biomarkers, Tumor; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D003561:Cytarabine; D014750:Vincristine; D010440:Peptichemio; D008558:Melphalan; D011241:Prednisone; D003630:Daunorubicin
La p170 nel mieloma multiplo e nelle leucemie acute.